PapersFlow Research Brief
Cardiac and Coronary Surgery Techniques
Research Guide
What is Cardiac and Coronary Surgery Techniques?
Cardiac and Coronary Surgery Techniques encompass surgical methods for treating coronary artery disease and cardiac conditions, including coronary artery bypass grafting (CABG) with on-pump and off-pump approaches, minimally invasive procedures, and assessments of neurocognitive function, inflammatory responses, graft patency, and postoperative outcomes.
The field includes 43,366 papers focused on coronary artery bypass surgery techniques, comparing on-pump versus off-pump methods, and evaluating impacts on neurocognitive function and inflammatory responses. Key studies examine graft patency using internal mammary artery grafts and neurologic outcomes like stroke after cardiac surgery. Research also covers minimally invasive surgery and its effects on cardiac outcomes.
Topic Hierarchy
Research Sub-Topics
On-Pump vs Off-Pump Coronary Surgery
This sub-topic compares cardiopulmonary bypass (on-pump) and beating-heart (off-pump) techniques in CABG regarding mortality, morbidity, and costs. Researchers conduct RCTs and meta-analyses on technique-specific outcomes.
Neurocognitive Outcomes After Cardiac Surgery
This sub-topic evaluates postoperative cognitive decline, delirium, and stroke risks following CABG. Researchers use neuropsychological batteries to track long-term brain function changes.
Inflammatory Response in Cardiopulmonary Bypass
This sub-topic investigates systemic inflammation from bypass circuits and its role in organ dysfunction. Researchers study biomarkers, anti-inflammatory agents, and circuit modifications.
Graft Patency in Coronary Revascularization
This sub-topic assesses long-term durability of saphenous vein, internal mammary, and radial artery grafts post-CABG. Researchers use angiography and imaging to evaluate failure rates.
Minimally Invasive Cardiac Surgery Techniques
This sub-topic explores port-access, robotic, and hybrid approaches for CABG and valve surgery. Researchers compare them to sternotomy on recovery time, pain, and outcomes.
Why It Matters
Cardiac and Coronary Surgery Techniques directly influence survival rates and quality of life in patients with coronary artery disease. An overview of 10-year results from randomized trials showed that coronary artery bypass graft surgery improves survival compared to medical therapy in specific patient groups (Yusuf et al., 1994, "Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration"). The SYNTAX trial's 5-year follow-up demonstrated that CABG outperforms percutaneous coronary intervention in patients with three-vessel or left main coronary disease, with lower major adverse cardiac events (Mohr et al., 2013, "Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial"). Neurocognitive decline persists after CABG, affecting up to a significant prevalence of patients long-term (Newman et al., 2001, "Longitudinal Assessment of Neurocognitive Function after Coronary-Artery Bypass Surgery"), while adverse cerebral outcomes increase mortality and hospitalization length (Roach et al., 1996, "Adverse Cerebral Outcomes after Coronary Bypass Surgery"). Guidelines like the 2018 ESC/EACTS recommendations standardize revascularization to optimize outcomes (Neumann et al., 2018, "2018 ESC/EACTS Guidelines on myocardial revascularization").
Reading Guide
Where to Start
"2018 ESC/EACTS Guidelines on myocardial revascularization" by Neumann et al. (2018), as it offers a comprehensive evidence-based framework for revascularization techniques, patient selection, and surgical decision-making, serving as an entry point before diving into specific trials.
Key Papers Explained
Neumann et al. (2018, "2018 ESC/EACTS Guidelines on myocardial revascularization") synthesize evidence from trials like Mohr et al. (2013, "Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial"), which compared CABG to PCI, and Yusuf et al. (1994, "Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration"), establishing long-term survival benefits of CABG. Newman et al. (2001, "Longitudinal Assessment of Neurocognitive Function after Coronary-Artery Bypass Surgery") and Roach et al. (1996, "Adverse Cerebral Outcomes after Coronary Bypass Surgery") build on outcomes data by quantifying neurocognitive and cerebral risks, informing guideline updates. Eagle et al. (1999, "ACC/AHA guidelines for coronary artery bypass graft surgery") provides complementary North American standards that align with European approaches.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Recent emphasis remains on refining on-pump versus off-pump CABG to minimize neurocognitive deficits and stroke risks, as highlighted in high-citation papers like Newman et al. (2001) and Roach et al. (1996), with no new preprints available to indicate shifts.
Papers at a Glance
Frequently Asked Questions
What are the guidelines for myocardial revascularization in cardiac surgery?
The "2018 ESC/EACTS Guidelines on myocardial revascularization" by Neumann et al. (2018) provide recommendations for coronary artery bypass grafting and percutaneous interventions based on evidence from clinical trials. These guidelines address patient selection for CABG versus stenting, emphasizing anatomy and comorbidities. They have received 6846 citations, reflecting their authoritative role in practice.
How does CABG compare to percutaneous coronary intervention in complex disease?
In patients with three-vessel or left main coronary disease, CABG showed superior 5-year outcomes over percutaneous coronary intervention in the SYNTAX trial (Mohr et al., 2013, "Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial"). CABG reduced major adverse cardiac or cerebrovascular events. This finding supports CABG for multivessel disease.
What is the impact of CABG on neurocognitive function?
Longitudinal assessment reveals high prevalence and persistence of cognitive decline after CABG, with early postoperative decline predicting later deterioration (Newman et al., 2001, "Longitudinal Assessment of Neurocognitive Function after Coronary-Artery Bypass Surgery"). Patients experience a pattern of initial improvement followed by decline. Interventions targeting early deficits may mitigate long-term effects.
What are adverse cerebral outcomes after coronary bypass surgery?
Adverse cerebral outcomes occur relatively commonly after CABG, linked to increased mortality, longer hospitalization, and greater use of care facilities (Roach et al., 1996, "Adverse Cerebral Outcomes after Coronary Bypass Surgery"). These include stroke and neurocognitive deficits. New strategies are needed to reduce their incidence.
How do sirolimus-eluting stents compare to standard stents in coronary revascularization?
A randomized trial showed sirolimus-eluting stents reduce neointimal proliferation, restenosis, and clinical events compared to standard stents (Morice et al., 2002, "A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization"). This improvement supports their use in preventing target vessel revascularization. The study involved 1101 patients with 5.4% restenosis rate versus 26.6% in controls.
What do ACC/AHA guidelines specify for CABG?
The "ACC/AHA guidelines for coronary artery bypass graft surgery" outline indications, techniques, and perioperative management for CABG (Eagle et al., 1999). They cover patient selection, surgical approaches, and outcome expectations. These guidelines serve as a standard reference with 1999 citations.
Open Research Questions
- ? How can neurocognitive decline after CABG be prevented, given its persistence and prediction by early postoperative changes?
- ? What strategies reduce adverse cerebral outcomes like stroke, which substantially increase mortality and hospitalization after coronary bypass surgery?
- ? In which patients does CABG provide the greatest survival benefit over medical therapy or PCI, based on long-term randomized trial data?
- ? How do progenitor cell transplantations enhance left ventricular function post-myocardial infarction, and what are optimal delivery methods?
- ? What factors determine graft patency differences between on-pump and off-pump CABG techniques?
Recent Trends
The field maintains steady focus on CABG outcomes, with 43,366 papers but no specified 5-year growth rate.
High-impact works like Neumann et al. (2018, "2018 ESC/EACTS Guidelines on myocardial revascularization", 6846 citations) continue to guide practice, while SYNTAX trial follow-up (Mohr et al., 2013, 1754 citations) reinforces CABG superiority in complex disease.
No recent preprints or news coverage indicate ongoing refinements in techniques amid established evidence.
Research Cardiac and Coronary Surgery Techniques with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Cardiac and Coronary Surgery Techniques with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers